Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Skovsgaard

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Cancer Research|December 1, 1978
Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cellsT Skovsgaard
Cancer Research|June 1, 1978
Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cellsT Skovsgaard
European Journal of Haematology. Supplementum|January 1, 1987
Pharmacodynamic aspects of aclarubicin with special reference to daunorubicin and doxorubicinT Skovsgaard
Cancer Chemotherapy and Pharmacology|January 1, 1979
In vitro and in vivo study of cross resistance between daunorubicin and daunorubicin-DNA complex in Ehrlich ascites tumorT Skovsgaard
Cancer Chemotherapy Reports|March 1, 1975
Development of resistance to rubidazone (NSC-164011) in Ehrlich ascites tumor in vivoT Skovsgaard
Biochemical Pharmacology|February 1, 1977
Transport and binding of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cellsT Skovsgaard
Biochemical Pharmacology|January 1, 1978
Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cellsT Skovsgaard
Cancer Research|April 1, 1980
Circumvention of resistance to daunorubicin by N-acetyldaunorubicin in Ehrlich ascites tumorT Skovsgaard
Biochimica Et Biophysica Acta|July 7, 1992
P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell linesD Nielsen, T Skovsgaard
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1988
Lectin staining patterns of plasma membranes of daunorubicin and vincristine resistant Ehrlich ascites tumour cellsM Sehested, T Skovsgaard
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Cancer Research|December 1, 1978
Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cellsT Skovsgaard
Cancer Research|June 1, 1978
Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cellsT Skovsgaard
European Journal of Haematology. Supplementum|January 1, 1987
Pharmacodynamic aspects of aclarubicin with special reference to daunorubicin and doxorubicinT Skovsgaard
Cancer Chemotherapy and Pharmacology|January 1, 1979
In vitro and in vivo study of cross resistance between daunorubicin and daunorubicin-DNA complex in Ehrlich ascites tumorT Skovsgaard
Cancer Chemotherapy Reports|March 1, 1975
Development of resistance to rubidazone (NSC-164011) in Ehrlich ascites tumor in vivoT Skovsgaard
Biochemical Pharmacology|February 1, 1977
Transport and binding of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cellsT Skovsgaard
Biochemical Pharmacology|January 1, 1978
Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cellsT Skovsgaard
Cancer Research|April 1, 1980
Circumvention of resistance to daunorubicin by N-acetyldaunorubicin in Ehrlich ascites tumorT Skovsgaard
Biochimica Et Biophysica Acta|July 7, 1992
P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell linesD Nielsen, T Skovsgaard
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1988
Lectin staining patterns of plasma membranes of daunorubicin and vincristine resistant Ehrlich ascites tumour cellsM Sehested, T Skovsgaard
Pageof 8